Clinical And Preclinical Finding In Influenza

Babamahmoodi, Farhang; Maboudi, Masoud; Hosainzade, Ghazale; Ebrahimi, Ata; Asghari, Faeze; Ahangarkani, Fateme; Kamali , Mahsa; Khalatbari, Azadeh

[Home ] [Archive]

International Journal of Medical Investigation

Main Menu

Home

Journal Information

Articles archive

For Authors

For Reviewers

Registration

Contact us

Site Facilities

Editorial Board

Search in website

Receive site information

Volume 11, Issue 4 (12-2022)

Int J Med Invest 2022, 11(4): 38-43

Back to browse issues page

Clinical And Preclinical Finding In Influenza

Farhang Babamahmoodi

, Masoud Maboudi ^*

Assistant Professor, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Abstract: (1085 Views)

Background: Influenza is an acute respiratory viral infection that threatens global health. Regular assessment of clinical and paraclinical symptoms is a very important tool for early diagnosis and disease management, transmission, and prevention of influenza, epidemics. The main purpose of this study was to evaluate the clinical and paraclinical symptoms of patients with influenza in the north of Iran.
Methods: This descriptive cross-sectional study was conducted on hospitalized patients through a convenience sampling method from September 2019 to February 2020 in a teaching hospital, in Iran. The inclusion criteria were age at least one year and the possibility of influenza based on at least one of the following clinical and paraclinical findings. Clinical manifestation, radiographic findings, and paraclinical findings had been assessed. Patients with hospitalization of fewer than three days and incomplete documents were excluded.
Results: Most of the patients were male (52.0%) and had a history of contact with positive influenza patients (88.3%). The most common symptoms were fever (89.9%), chills (76.9%), cough (67.5%), and sore throat (41.2%), respectively. It was no significant difference between WBC, LDH, and CPK in less than 12 years old vs. above 12 years old (p>0.05). But, the platelet was a significant difference between less than 12 years old vs. above 12 years old.
Conclusions: The results of the present study provide a rationale for annual vaccination and other preventive measures against influenza. Also, this study was the last study in relation to influenza before the COVID-19 pandemic and the extracted data can be useful to compare influenza and COVID-19.

Keywords: Influenza Disease, Acute Respiratory Infection, Symptom of Disease

Full-Text [PDF 476 kb] (1023 Downloads)

Type of Study: Review | Subject: General

References

1. 1. Mohebbi A FF, Jamali A, Yaghobi R, Farahmand B, Mohebbi R. . Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran. Virus research. 2019;259:38-45. 2. Ryu S, Cowling BJ. Human influenza epidemiology. Cold Spring Harbor Perspectives in Medicine. 2021;11(12):a038356. 3. Wang Y ST, Li K, Jin Y, Yue J, Ren H, et al. . Different subtypes of influenza viruses target different human proteins and pathways leading to different pathogenic phenotypes. . BioMed research international. 2019:2019. 4. Sanz J, MT VA. Influenza and cardiorespiratory events: a clinical-epidemiological review with a multidisciplinary point of view. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia. 2021;34(6):556-68. 5. Yokomichi H MM, Lee JJ, Kojima R, Yokoyama T, Yamagata Z. Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data. . BMJ open. 2019;9(1):e024687. 6. Maldonado YA, O’Leary ST, Ardura MI, Banerjee R, Bryant KA, Campbell JD, et al. Recommendations for prevention and control of influenza in children, 2021–2022. Pediatrics. 2021;148(4). 7. Stewart RJ FB, Chung JR, Gaglani M, Reis M, Zimmerman RK, et al. Influenza antiviral prescribing for outpatients with an acute respiratory illness and at high risk for influenza-associated complications during 5 influenza seasons—United States, 2011–2016 . Clinical Infectious Diseases. 2018;66(7):1035-41. 8. Lee K, Chen Y-H, Huang C-H, Hsu J-C, Chang Y-C, Kuo H-J, et al. A multicenter cohort study of severe dengue and critically ill influenza patients with elevated cardiac troponin-I: Difference clinical features and high mortality. Travel Medicine and Infectious Disease. 2022;47:102281. 9. Campos-Outcalt D. Influenza vaccine update, 2021-22. The Journal of Family Practice. 2021;70(8):399-402. 10. Ward BJ MA, Séguin A, Pillet S, Trépanier S, Dhaliwall J, et al. . Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥ 65 years): two multicentre, randomised phase 3 trials. . The Lancet. 2020. 11. Palomba E, Castelli V, Renisi G, Bandera A, Lombardi A, Gori A, editors. Antiviral Treatments for Influenza. Seminars in Respiratory and Critical Care Medicine; 2021: Thieme Medical Publishers, Inc. 12. Tchilian E HB, Morgan SB, Martini V, Sharma R, Clark B, et al. Immunogenicity and protective efficacy of seasonal human live attenuated cold-adapted influenza virus vaccine in pigs. Frontiers in immunology. 2019;10:2625. 13. Kharroubi G, Cherif I, Bouabid L, Gharbi A, Boukthir A, Ben Alaya N, et al. Influenza vaccination knowledge, attitudes, and practices among Tunisian elderly with chronic diseases. BMC geriatrics. 2021;21(1):1-9. 14. Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y, et al. Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons. Virology Journal. 2022;19(1):1-11. 15. Haghshenas M, Jafarian E, Babamahmoodi F, Tabrizi A, Nandoost S, Alizadeh-Navaei R. Prevalence of influenza A/H3N2 virus in northern Iran from 2011 to 2013. Caspian journal of internal medicine. 2015;6(2):116. 16. Javanian M, Babazadeh A, Ebrahimpour S, Shokri M, Bayani M. Clinical and laboratory findings of patients with the possible diagnosis of influenza hospitalized in affiliated hospitals of Babol University of Medical Sciences, 2015-2016. Current Issues in Pharmacy and Medical Sciences. 2018;31(3):113-6. 17. Momen-Heravi M, Afzali H, Soleimani Z, Sharif A, Razzaghi R, Moravvegi SA, et al. Clinical Presentation and Final Outcome in Definite Cases of Influenza A (H1N1) in Kashan, Iran. Zahedan J Res Med Sci. 2015;17(1):37-9. 18. Yan Q, Zhong J, Zhou H, Zhou J. Clinical and epidemiological characteristics of 245 cases of influenza A (H3N2). Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese Journal of Tuberculosis and Respiratory Diseases. 2019;42(7):510-4. 19. Nypaver C, Dehlinger C, Carter C. Influenza and influenza vaccine: A review. Journal of Midwifery & Women's Health. 2021;66(1):45-53.

Add your comments about this article

Mendeley

Zotero

RefWorks

Babamahmoodi F, Maboudi M, Hosainzade G, Ebrahimi A, Asghari F, Ahangarkani F, et al . Clinical And Preclinical Finding In Influenza. Int J Med Invest 2022; 11 (4) :38-43
URL: http://intjmi.com/article-1-930-en.html

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Volume 11, Issue 4 (12-2022)

Back to browse issues page

Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4660